Category: Clinical Trials

Dr. Nawaid Usmani and team receive funding for their PRIME study!

April 15, 2016

The PRIME Study – Prevention and Intervention for MEtabolic syndrome: […]

The Calgary Prostate Cancer Centre has the highest accrual for a novel ultrasound study in prostate cancer

December 15, 2015

“We have enrolled over 400 patients at our site, reaching […]

The Alberta Prostate Cancer Biorepository is certified by CTRNet

December 9, 2015

APCaRI is committed to collecting, processing and storing the samples […]

APCaRI is part of the Movember Prostate Cancer Outcomes network

The Prostate Cancer Outcomes Global Initiative to Compare and Reduce Variation is a project led by Movember aiming to improve health outcomes for men throughout their prostate cancer journey by focusing on variation in care and engaging clinicians and researchers across 14 countries worldwide.

The international team will collect data from prostate cancer patients segmented into the categories of data items as outlined by the International Consortium for Health Outcomes Measurement (ICHOM). These include patient factors, baseline tumor factors, pathological information, treatment variables, acute complications of treatment, and survival and disease control).

The Alberta Prostate Cancer dataset is highly aligned with the ICHOM standards. This means that we can effectively compare treatments and outcomes in Alberta with teams around the world to find ways to improve our care at home and abroad!

This is the result of hours of planning and true team work lead by Dr. Trafford Crump, the APCaRI Scientific and Data Quality Committee, and the APCaRI clinical, scientific, research and pathology teams. Thanks to your efforts, we are one step closer to improving patient outcomes.

- John Lewis